FolioLanternBeta
SEPNSepterna, Inc.

Shalini Sharp

Director at Septerna, Inc., as of Jun 30, 2026No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
3
companies filed for

Last filing: Jun 30, 2026. Most recent sale before this period: May 17, 2024.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Septerna, Inc. (SEPN)DirectorOct 24, 2024Jun 30, 2026
BeOne Medicines Ltd. (ONC)DirectorOct 2, 2024Jun 15, 2026
Neurocrine Biosciences Inc (NBIX)DirectorFeb 4, 2020May 29, 2026

Also a director at

BeOne Medicines Ltd. (ONC), Neurocrine Biosciences Inc (NBIX)

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.